Invited Review: For the clinical application of thermochemotherapy given at mild temperatures

References

• AGGARWAL, B. B., EESSALU, T. E., and HASS, P. E., 1985, Characterization of receptors for human tumour necrosis by y-interferon. Nature, 318, 665–667.
   PubMed Web of Science ®Google Scholar
• ALEXANDER, H. R., FRAKER, D. L., and BARTLETT, D. L., 1996, Isolated limb perfusion for malignant melanoma. Seminars in Surgical Oncology, 12, 416–428.
   PubMedGoogle Scholar
• BABA, H., SIDDIK, Z. H., STREBEL, F. R., JENKEN, G. N., and BULL, J. M. C., 1989, Increased therapeutic gain of combined cis-diamminedichloroplatinum(II) and whole body hyper-thermia therapy by optimal heat/drug scheduling. Cancer Research, 49, 7041–7044.
   PubMed Web of Science ®Google Scholar
• BALKWILL, F. R., LEE, A. L., ALDAM, E., THOMAS, J. A., TAVERNIER, J., and FIERS, W., 1986, Human tumour xenografts treated with recombinant human tumor necrosis fac-tor alone or in combination with interferons. Cancer Research, 46, 3990–3993.
   PubMed Web of Science ®Google Scholar
• BARTLETT, D. L., MA, G., ALEXANDER, H. R., LIBUTTI, S. K., and FRAKER, D. L., 1997, Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics. Cancer, 80, 2084–2090.
   PubMed Web of Science ®Google Scholar
• BEGG, A. C., and SMITH, K. A., 1984, A bioassay for cyclophosphamide in blood, lung, and tumour. British Journal of Cancer, 49, 49–55.
   PubMed Web of Science ®Google Scholar
• BORNSTEIN, B. A., HERMAN, T. S., HANSEN, J. L., BUSWELL, L., ZOURANJIAN, P. S., FRASER, S. M., TEICHER, B. A., SVENSSON, G. K., and COLEMAN, C. N., 1995, Pilot study of local hyperthermia, radiation therapy, ethanidazole, and cis-platin for advanced super-ficial tumours. International Journal of Hyperthermia, 11, 489–499.
   PubMed Web of Science ®Google Scholar
• BULL, J. M., LEES, D., SCHUETTE, W., WHANG-PENG, J., SMITH, R., BYNUM, G., ATKINSON, E. R., GOTTDIENER, J. S., GRAHLNICK, H. R., SHAWKER, T. H., and DEVITA, JR., V. T., 1979, Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemo-therapy. Annals of Internal Medicine, 90, 317–323.
   Google Scholar
• COLOMBO, R., DA Pozzo, L. F., LEV, A., FRESCHI, M., GALLUS, G., and RIGATTI, P., 1996, Neoadjuvant combined microwave induced local hyperthermia and topical chemo-therapy versus chemotherapy alone for superficial bladder cancer. Journal of Urology, 155, 1227–1232.
   PubMed Web of Science ®Google Scholar
• COLOMBO, R., LEV, A., DA Pozzo, L. F., FRESCHI, M., GALLUS, G., and RIGATTI, P., 1995, A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. Journal of Urology, 153, 959–963.
   PubMed Web of Science ®Google Scholar
• COLVIN, M., and BRUNDRETT, R., 1981, Chemical decomposition of chloroethylnitrosoureas. Nitrosoureas: Current Status and New Developments, edited by A. W. Prestayko, L. H. Baker, S. T. Crooke, S. K. Carter, P. S. Schein and N. A. Alder (New York: Academic Press), pp. 43–49.
   Google Scholar
• DI FLIPPO, F., CALABRO, A., GIANNARELLI, D., CARLINI, S., CAVALIERE, F., MOSCARELLI, F., and CAVALIERE, R., 1989, Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer, 63, 2551–1561.
   PubMed Web of Science ®Google Scholar
• DOUPLE, E. B., STROHBEHN, J. W., DE SIEYES, D. C., ALBOROUGH, D. P., and TREMBLY, B. S., 1982, Therapeutic potentiation of cis-dichlorodiammineplatinum (II) and radiation by interstitial microwave hyperthermia in a mouse tumor. National Cancer Institute Monograph, 61, 259–262.
   Google Scholar
• DURSE, L., COVEY, J. M., COLLINS, C., and SINHA, B. K., 1989, DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells. Chemical Biological Interaction, 71, 63–78.
   PubMed Web of Science ®Google Scholar
• EICHOLTZ-WIRTH, H., and HIETEL, B., 1986, The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro. British Journal of Cancer, 54, 239–243.
   PubMed Web of Science ®Google Scholar
• EGGERMONT, A. M. M., KOOPS, H. S., KLAUSNER, J. M., KROON, B. B. R., SCHLAG, P. M., BEN-ARI, G., and LEJEUNE, F. J., 1997, Isolated limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas. Seminars in Oncology, 24, 547–555.
   Google Scholar
• EGGERMONT, A. M. M., KOOPS, H. S., KLAUSNER, J. M., KROON, B. B. R., SCHLAG, P. M., LIENARD, D., VAN GEEL, A. N., HOEKSTRA, H. J., MELLAER, I., NIEWEG, O. E., KELLELHACK, C., BEN- ARI, G., PECTOR, J.-C., and LEJEUNE, F. J., 1996a, Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas: The cumulative multi-center European experience. Annals of Surgery, 224, 756–765.
   Google Scholar
• EGGERMONT, A. M. M., KOOPS, H. S., LIENARD, D., KROON, B. B. R., VAN GEEL, A. N., HOEKSTRA, H. J., and LEJEUNE, F. J., 1996b, Isolated limb perfusion with high-dose tumor necrosis factor-a in combination with interferon-y and melphalan for non-resectable extremity soft tissue sarcomas: A multicenter trial. Journal of Clinical Oncology, 14, 2653–2665.
   Google Scholar
• ENGELHARDT, R., 1988, Summary of recent clinical experience in whole-body hyperthermia combined with chemotherapy. Recent Results in Cancer Research, 107, 200–204.
   PubMedGoogle Scholar
• FRAKER, D. L., ALEXANDER, H. L., ANDRICH, M., and ROSENBERG, S. A., 1996, Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necro-sis factor dose-escalation study. Journal of Clinical Oncology, 14, 479–489.
   PubMed Web of Science ®Google Scholar
• FUJIMOTO, S., TAKAHASHI M., MUTOU, T., KOBAYASHI, K., TOYOSAWA, T., IsAwA E., SUMIDA, M., and OHKuso, H., 1997, Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer, 79, 889–891.
   Google Scholar
• FUJIMURA, T., YONEMURA, Y FUSHIDA, S., URADE, M., TAKEGAWA, S., KAMATA, T., SUGIYAMA, K., HASEGAWA, H., KATAYAMA, K., MIWA, K., and MIYAZAWA, I., 1990, Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemi-nation in gastric cancers and subsequent second-look operation. Cancer, 65, 65–71.
   Google Scholar
• GUTMAN, M., INBAR, M., LEV-SHLUSH, D., ABU-ABID, S., MOZES, M., CHAITCHIK, S., MELLER, I., and KLAUSNER, J. M., 1997, High dose tumor necrosis factor-a and mel-phalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a 90% response rate and limb preservation. Cancer, 79, 1129–1137.
   PubMed Web of Science ®Google Scholar
• HAFSTROEM, L. R., HOLMBERG, S. B., NAREDI, P. L. J., LINDNER, R. G., BENGTSSON, A., TIDEBRANT, G., and SCHERSTEN, T. S. O., 1994, Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surgical Oncology, 3, 103–108.
   PubMed Web of Science ®Google Scholar
• HAFSTROEM, L., RUDENSTAM, C.-M., BLOMQUIST, E., INGVAR, C., JAENSSON, P.-E., LAGERLOEF, B., LINDHOLM, C., RINGBORG, U., WESTMAN, G., and LEIF OESTRUP for The Swedish Melanoma Study Group, 1991, Regional hyperthermia with melphalan after surgery for recurrent malignant melanoma of the extremities. Journal of Clinical Oncology, 9, 2091–2094.
   Google Scholar
• HAHN, G. M., 1975, Thermochemotherapy: Interactions between hyperthermia and chemo-therapeutic agents. Proceedings of International Symposium on Cancer Therapy by Hyperthermia and Radiation, Washington, DC, pp. 61–65.
   Google Scholar
• HAJARIZADEH, H., MUELLER, C. R., WOLTERING, E. A., SMALL, K., and FLETCHER, W. S., 1991, Phase I—II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremities. Melanoma Research, 1, 55–61.
   PubMedGoogle Scholar
• HASSANZADEH, M., and CHAPMAN, I. V., 1982, Thermal enhancement of bleomycin-induced growth delay in a squamous carcinoma of CBA/HT mouse. European Journal of Cancer Clinical Oncology, 18, 795–797.
   PubMedGoogle Scholar
• HAZ EN, G., BEN-HUR, E., and YERUSHALMI, A., 1981. Synergism between hyperthermia and cyclophosphamide in vivo: The effect of dose fractionation. European Journal of Cancer, 17, 681–684.
   Google Scholar
• HERMAN, T. S., TEICHER, B. A., CHAN, V., COLLINS, L. S., KAUFMAN, M. E., and Loll, C., 1988a, Effect of hyperthermia on the action of cis-diamminedichloroplatinum (II), Rhodamine 1232 [tetrachloroplatinum (II)], Rhodamine 123, and potassium etrachloro-platinate in vitro and in vivo. Cancer Research, 48, 2335–2341.
   PubMed Web of Science ®Google Scholar
• HERMAN, T. S., TEICHER, B. A., HOCHELSON, M., CLARK, J., SVENSSON, G., and COLEMAN, C. N., 1988b, Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advance human malignancies. International Journal of Hyperthermia, 4, 143–158.
   PubMed Web of Science ®Google Scholar
• HILL, S., FAWCETT, W. J., SHELDON, J., SONI, N., WILLIAMS, T., and THOMAS, J. M., 1993, Low-dose tumour necrosis factor a and melphalan in hyperthermic isolated limb perfu-sion. British Journal of Surgery, 80, 995–997.
   PubMed Web of Science ®Google Scholar
• HOEKSTRA, H. J., KOOPS, H. S., DE VERIES, L. G. E., VAN WEERDEN, T. W., and OLDHOFF, J., 1993, Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment. Cancer, 72, 1224–1229.
   Google Scholar
• HOEKSTRA, H. J., KOOPS, H. S., MOLENAAR, W. M., and OLDHOFF, J., 1987, Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities. Cancer, 60, 1703–1707.
   PubMed Web of Science ®Google Scholar
• HONESS, D. J., and BLEEHEN, N. M., 1982, Sensitivity of normal mouse marrow and RIF-1 tumor to hyperthermia combined with cyclophosphamide or BCNU: A lack of thera-peutic gain. British Journal of Cancer, 46, 236–248.
   PubMed Web of Science ®Google Scholar
• HONESS, D. J., and BLEEHEN, N. M., 1985, Thermochemotherapy with cis-platinum, CCNU, BCNU chlorambucil and melphalan on murine marrow and two tumours: Therapeutic gain for melphalan only. British Journal of Radiology, 58, 63–72.
   PubMed Web of Science ®Google Scholar
• HORSMAN, M. R., and OVERGAARD, J., 1997, Can mild hyperthermia improve tumour oxy-genation? International Journal of Hyperthermia, 13, 141–147.
   Google Scholar
• JOHNSON, H. A., and PAVELEC, M., 1973, Thermal enhancement of thio-TEPA cytoxicity. Journal of National Cancer Institute, 50, 903–908.
   PubMedGoogle Scholar
• KAIJSER, G. P., BEIJNEN, J. H., BULT, A., and UNDERBERG, W. J., 1994, Ifosfamide metab-olism and pharmacokinetics (review). Anticancer Research, 14, 517–532.
   PubMed Web of Science ®Google Scholar
• KAKEHI, M., UEDA, K., MUKOJIMA, T., HIRAOKA, M., SETO, O., AKANUMA, A., and NAKATSUGAWA, S., 1990, Multi-institutional clinical studies on hyperthermia combined with radiotherapy of chemotherapy in advanced cancer of deep-seated organs. International Journal of Hyperthermia, 6, 719–740.
   PubMed Web of Science ®Google Scholar
• KLAASE, J. M., KROON, B. B. R., BEIJNEN, J. H., VAN SLOOTEN. G. W., and VAN DONGEN. J. A., 1994, Melphalan tissue concentrations in patients with regional isolated perfusion for melanoma of the lower limb. British Journal of Cancer, 70, 151–153.
   Google Scholar
• KLAASE, J. M., KROON, B. B. R., BENCKHUIJSEN, C., VAN GEEL, A. N., ALBUS-LUTTER, C. E., and WIEBERDINK, J., 1989, Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities. Cancer, 64, 616–621.
   Google Scholar
• KLOSTERGAARD, J., LEROUX, E., SIDDIK, Z. H., KHODADADIAN, M., and TOMASOVIC, S. P., 1992, Enhanced sensitivity of human colon tumor cell in vitro in response to thermo-chemoimmunotherapy. Cancer Research, 52, 5271–5277.
   PubMed Web of Science ®Google Scholar
• KURODA, M., and URANO, M., 1997, Thermal enhancement of the effect of ifosfamide against a spontaneous murine fibrosarcoma, FSa-II. International Journal of Hyperthermia, 13, 125–131.
   PubMed Web of Science ®Google Scholar
• KURODA, M., URANO, M., NISHIMURA, Y., and REYNOLDS, R., 1997, Induction thermo-chemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma. International Journal of Radiation Oncology Biology and Physics, 38, 411–417.
   PubMed Web of Science ®Google Scholar
• LEHTI, P. M., MOSELEY, H. S., JANOFF, K., STEVEN, K., FLETCHER, W. S., 1986, Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy. Surgery, Gynecology & Obstetrics, 162, 149–152.
   PubMedGoogle Scholar
• LEJEUNE, F. J., 1995, High dose recombinant tumour necrosis factor (rTNFcc) administered by isolation perfusion for advanced tumors of the limbs: A model for biochemotherapy of cancer. European Journal of Cancer, 31A, 1009–1016.
   PubMed Web of Science ®Google Scholar
• LIENARD, D., EGGERMONT, A. M. M., KOOPS, H. S., KROON, B. B. R., ROSENKAIMER, F., AUTIER, P., and LEJEUNE, F. J., 1994, Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-a), interferon-gamma (INF-y) and melphalan for melanoma stage III. Results of a multi-centre pilot study. Melanoma Research, 4, (Suppl. 1), 21–26.
   Google Scholar
• LIENARD, D., EWALENKO, P., DELMOTTE, J.-J., RENARD, N., and LEJEUNE, F. J., 1992, High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan ion solution perfusion of the limbs for melanoma and sarcoma. Journal of Clinical Oncology, 10, 52–60.
   Google Scholar
• LINDEGAARD. J., RADACIC, M., KHALIL, A. A., HORSMAN, M. R., and OVERGAARD, J. 1992, Cisplatin and hyperthennia treatment of a C3H mammary carcinoma in vivo. Acta Oncologica, 31, 347–351.
   PubMed Web of Science ®Google Scholar
• LITTERST, C. L., 1984, Plasma pharmacokinetics, urinary excretion, and tissue distribution of platinum following iv administration of cyclobutanedicarboxyatoplatinum-II and cis-platin, to cis-platinum to rabbits. Platinum Coordination Complexes in Cancer Chemotherapy, edited by M. P. Hacker, E. B. Douple and I. H. Krakoff (Martinus Nijhoff), pp. 71–81.
   Google Scholar
• MARTJIN, H., OLDHOFF, J., and KOOPS, H. S., 1982, Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanoma of the extremities. Journal of Surgical Oncology, 20, 9–13.
   PubMed Web of Science ®Google Scholar
• MELLA, O., 1985, Combined hyperthennia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4A tumours. International Journal of Hyperthermia, 1, 171–184.
   PubMedGoogle Scholar
• MINI, E., DOMBROWSKI, J., MOROSON, B. A., and BERTINO, J. R., 1986, Cytotoxic effects of hyperthermia, 5-fluorouracil and their combination on a human leukemia T-lympho-blast cell line, CCRF-CEM. European Journal of Cancer Clinical Oncology, 22, 927–934.
   PubMedGoogle Scholar
• MONGE, O. R., and ROFSTAD, E. K., 1989, Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: thermotolerant tumours. International Journal of Hyperthermia, 5, 579–587.
   PubMed Web of Science ®Google Scholar
• MONGE, O. R., ROFSTAD, E. K., and KAALHUS, O., 1988, Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: Single fraction heat and drug treatment. European Journal of Cancer, 24, 1661–1669.
   Web of Science ®Google Scholar
• NISHIMURA, Y., ONO, K., HIRAOKA, M., MASUNAGA, S-I., JO, S., SHIBAMOTO, Y., SASAI, K., ABE, M., IGA, K., and OGAWA, Y., 1990, Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiation Research, 122, 161–167.
   PubMed Web of Science ®Google Scholar
• OLESON, J. R., 1995, Hyperthermia from the clinic to the laboratory: a hypothesis. Eugene Robertson Special Lecture. International Journal of Hyperthermia, 11, 315–322.
   PubMed Web of Science ®Google Scholar
• OLIEMAN, A. F. T., PRA, E., VAN GINKEL, R. J., MOLENAAR, W. M., KOOPS, H. S., and HOEKSTRA, H. J., 1998, Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-a and melphalan for limb-saving treat-ment in locally advanced extremity soft-tissue sarcoma. International Journal of Radiation Oncology, Biology and Physics, 40, 807–814.
   Google Scholar
• OVERGAARD, J., GONZALEZ GONZALEZ, D., HULSHOF, M. C. C. H., ARCANGELI, G., DAHL, O., MELLA, O., and BEMNTZEN, S. M., 1996. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. International Journal of Hyperthermia, 12, 3–20.
   Google Scholar
• PASS, H. I., MEW, D. J. Y., KRANDA, K. C., TEMECK, B. K., DONINGTON, J. S., and ROSENBERG, S. A., 1996, Isolated lung perfusion with tumor necrosis factor for pul-monary metastasis. Annals of Thoracic Surgery, 61, 1609–1617.
   PubMed Web of Science ®Google Scholar
• REGENASS, U., MUELLER, M., CURSCHELLAS, E., and MATTER, A., 1987, Antitumor effects of tumor necrosis factor in combination with chemotherapeutic agents. International Journal of Cancer, 39, 266–270.
   PubMed Web of Science ®Google Scholar
• ROBINS, H. I., COHEN, J. D., SCHMITT, C. L., TUITSCH, K. D., FEIERABEND, C., ARZOOMANIAN, R. Z., D'OLIERE, F., LONGO, W., HEISS, C., RUSHING, D., LOVE, R., and SPRIGGS, D., 1993, Phase I clinical trial of carboplatin and 41.8°C whole-body hyperthermia in cancer patients. Journal of Clinical Oncology, 11, 1787–1794.
   Google Scholar
• ROSE, W. C., VERAS, G. H., LASTER, W. R., and SCHABEL, F. M., JR., 1979, Evaluation of whole-body hyperthermia as an adjuvant to chemotherapy in murine tumors. Cancer Treatment Report, 63, 1311–1325.
   Google Scholar
• SANTINAMI, M., DERACO, M., AZZARELLI, A., CASCINELLI, F., CHITI, A., COSTAGLI, V., INGLESE, M. G., MANZI, R., QUAGLIOLO, V., REBUFFONI, G., SANTORO, N., and VAGLINI, M., 1996, Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan. Tumori, 82, 579–584.
   PubMed Web of Science ®Google Scholar
• SCOTT, R. N., KERR, D. J., BLACKIE, R., HUGHES, J., BURNSIDE, G., MAcKIE, R. M., BYRNE, D. S., and MACKAY, A. J., 1992, The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma. British Journal of Cancer, 66, 159–166.
   PubMed Web of Science ®Google Scholar
• SONG, C. W., KANG, M. S., RHEE, J. G., and LEVITT, S. H., 1980, The effect of hyperthermia on vascular function, pH, and cell survival. Radiology, 137, 795–803.
   PubMed Web of Science ®Google Scholar
• SONG, C. W., SHAKIL, A., OSBORN, J. L., and IWATA, K., 1996, Tumour oxygenation is increased by hyperthermia at mild temperatures. International Journal of Hyperthermia, 12, 367–373.
   PubMed Web of Science ®Google Scholar
• STEHLIN, J. S., GIOVANELLA, B. S., DE IOPLYI, P. D., and ANDERSON, R. F., 1979, Eleven years' experience with hyperthermic perfusion for melanoma of the extremities. Cancer Research, 39, 2255–2257.
   PubMed Web of Science ®Google Scholar
• STERLIN, J. S., GIOVANELLA, B. C., DE IPOLYI, P. D., MUENZ, L. R., and ANDERSON, R. F., 1975, Results of hyperthermic perfusion for melanoma of the extremities. Surgery Gynecology & Oncology, 140, 339–348.
   PubMed Web of Science ®Google Scholar
• STORM, F. K., 1989, Clinical hyperthermia and chemotherapy. Radiological Clinic of North America, 27, 621–627.
   PubMed Web of Science ®Google Scholar
• STORM, F. K., BAKER, H. W., SCANLON, E. F., PLENK, H. P., MEADOWS, P. M., COHEN, S. C., OLSON, C. E., THOlVISON, J. W., KHANDEKAR, J. D., ROE, D., NIZZE A., and MORTON, D. L., 1985, Magnetic-induction hyperthermia: Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients. Cancer, 55, 2677–2687.
   Google Scholar
• STORM, F. K., A R —ISER, L. R., GOODNIGHT J. E., HARRISON, W. H., ELLIOTT, R. S., GOMES, A. S., and MORTON, D. L., 1982, Thermochemotherapy for melanoma metastases in liver. Cancer, 49, 1243–1248.
   Google Scholar
• SUGIMACHI, K., KUWANO, H., IDE, H., TOGE, T., SAKU, M., and OSHIUMI, Y., 1994, Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. International Journal of Hyperthermia, 10, 485–493.
   PubMed Web of Science ®Google Scholar
• SUGIYAMA, A., KATAYAMA, M., MATSUDA, T., KAWAI, H., TONOOKA, M., TERASAKI, M., OKAMOTO, Y., SANO, E., and OKAMOTO, A., 1997, Hepatic arterial infusion chemo-therapy combined with hypethermia for metastatic liver tumors of colorectal cancer. Seminars in Oncology, 24 (Suppl. 6), 135–138.
   Google Scholar
• TAKAHASHI, M., FUJIMOTO, S., KOBAYASHI, K., MUTOU, T., KURE, M., MASAOKA, H., SHINANAKAYA, R. B., TAKAI, M., ENDOH, F., and OHKUBO, H., 1994, Clinical outcome of intraoperative pelvic hyperthermo-chemotherapy for patients with Dukes' C rectal cancer. International Journal of Hyperthermia, 10, 749–754.
   PubMed Web of Science ®Google Scholar
• THOM, A. K., ALEXANDER, H. R., ANDRICH, M. P., ROSENBERG, S. A., and FRAKER, D. L., 1995, Cytokine levels and systemic toxicity in patients undergoing isolated limb perfu-sion with high-dose tumor necrosis factor, interferon gamma, and melphalan. Journal of Clinical Oncology, 13, 264–273.
   PubMed Web of Science ®Google Scholar
• THOMPSON, J. F., and GIANOUTSOS, M. P., 1992, Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs. World Journal of Surgery, 16, 227–233.
   PubMed Web of Science ®Google Scholar
• TOHNAI, I., GOTO, Y., HAYASHI, Y., UEDA, M., KOBAYASHI, T., and MATSUI, M., 1996, Preoperative thermochemotherapy of oral cancer using magnetic induction hyper-thermia (Implant Heating System: IHS). International Journal of Hyperthermia, 12, 37–47.
   PubMed Web of Science ®Google Scholar
• TOLLEY, D. A., HARGREAVE, T. B., SMITH, P. H., WILLIAMS, J. L., GRIGOR, K. M., PARMAR, M. K., FREEDMAN, L. S., and UNSCINSKA, B. M., 1988, Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council subgroup on superficial bladder cancer (Urological Cancer Working Party). British Medical Journal, 296, 1759–1761.
   PubMed Web of Science ®Google Scholar
• URANO, M., 1994, Thermochemotherapy: from in vitro and in vivo experiments to potential clinical application, Hyperthermia and Oncology, vol. 4, edited by M. Urano and E. Douple (VSP), pp. 169–204.
   Google Scholar
• URANO, M., and KAHN, J., 1989, The effect of bleomycin administered in combination with hyperthermia on a C3H mouse fibrosarcoma. International Journal of Hyperthermia, 5, 377–382.
   PubMed Web of Science ®Google Scholar
• URANO, M., and KIM, M. S., 1983, The effect of hyperglycemia on thermochemotherapy of a spontaneous murine fibrosarcoma. Cancer Research, 43, 3041–3044.
   PubMed Web of Science ®Google Scholar
• URANO, M., BEGLEY, J., and REYNOLDS, R., 1994, Interaction between adriamycin cytotoxi-city and hyperthennia: growth-phase-dependent thermal sensitization. International Journal of Hyperthermia, 10, 817–826.
   PubMed Web of Science ®Google Scholar
• URANO, M., GERWECK, L. E., EPSTEIN, R., CUNNINGHAM, M., and SUIT, H. D., 1980, Response of a spontaneous murine tumor to hyperthermia: Factors which modify the thermal response in vivo. Radiation Research, 83, 312–322.
   PubMed Web of Science ®Google Scholar
• URANO, M., KAHN, J., and KENTON, L. A., 1986, Thermochemotherapy (combined cyclo-phosphamide and hyperthermia) with or without hyperglycemia as an adjuvant to radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 12, 45–50.
   PubMed Web of Science ®Google Scholar
• URANO, M., KAHN, J., and KENTON, L., 1988, Effect of bleomycin on murine tumor cells at elevated temperatures and two different pH values. Cancer Research, 48, 615–619.
   PubMed Web of Science ®Google Scholar
• URANO, M., KAHN, J., and KENTON, L. A., 1990a, The effect of cis-diamminedichloroplatinum(H) treatment at elevated temperatures on murine fibrosar-coma, FSa-II. International Journal of Hyperthermia, 6, 563–570.
   PubMed Web of Science ®Google Scholar
• URANO, M., KAHN, J., MAJIMA, H., and GERWECK, L. W., 1990b, The cytotoxic effect of cis-diamminedichroloplatinum (II) on cultured Chinese hamster cells at elevated tempera-tures. International Journal of Hyperthermia, 6, 581–590.
   PubMed Web of Science ®Google Scholar
• URANO, M., KAHN, J., and REYNOLDS, R., 1991a, The effect of 5-fluorouracil at elevated temperatures on a spontaneous mouse tumour: Arrhenius analysis and tumour response. International Journal of Radiation Biology, 59, 239–249.
   PubMed Web of Science ®Google Scholar
• URANO, M., KIM, M. S., KAHN, J., KENTON, L. A., and Li, M. L., 1985, Effect of thermo-chemotherapy (combined cyclophosphamide and hyperthermia) given at various tem-peratures with or without glucose administration on a murine fibrosarcoma. Cancer Research, 45, 4162–4166.
   PubMed Web of Science ®Google Scholar
• URANO, M., MAJIMA, H., and KAHN, J., 1991b, Cytotoxic effect of 1, 3 bis(2-chloroethyl)-N-nitrosourea at elevated temperatures: Arrhenius plot analysis and tumor response. International Journal of Hyperthermia, 7, 499–510.
   PubMed Web of Science ®Google Scholar
• URANO, M., WONG, K.-H., REYNOLDS, R., and BEGLEY, J., 1995, The advantageous use of hypoxic tumor cells in cancer therapy: Identical chemo sensitization by metronidazole and misonidazole at moderately elevated temperatures. International Journal of Hyperthermia, 11, 379–388.
   Google Scholar
• VAGLINI, M., BELLI, F., AMMATUNA, M., INGLESE, M. G., MANZI, R., PRAHA, A., PERSIANI, L., SANTINAMI, M., SANTORO, N., and CASCINELLI, N., 1994, Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan. Cancer, 73, 483–492.
   PubMed Web of Science ®Google Scholar
• VAN BREE, C., RIETBROEK, R., SCHOPMAN, E. M., Kipp, J. B., and BAKKER, P. J. M., 1996, Local hyperthermia enhances the effect of cis-diamminedichloro-platinum(H) on non-irradiated and preirradiated rat solid tumors. International Journal of Radiation Oncology, Biology and Physics, 36, 135–140.
   PubMed Web of Science ®Google Scholar
• VON SZ CZ EPAUSKI, L., and TROTT, K. R., 1981, The combined effect of bleomycin and hyper-thermia on the adenocarcinoma 284 of the C3H mouse. European Journal of Cancer, 17, 997–1000.
   Google Scholar
• WIEDEMANN, G. J., D'OLEIRE, F., KNOP, E., ELEFTHERIADIS, S., BUCSKY, P., FEDDERSEN, S., KLOUCHE, M., GEISLER, J., MENTEL, M., SCHUCKER, P., FEYERABEND, WEISS, C., and WAGNER, T., 1994, Ifosfamide and carboplatine combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Research, 54, 5346–5350.
   Google Scholar
• WIEDEMANN, G. J., SIEMENS, H. J., MENTZ EL, M., BIERSACK, A., WOESSMANN, W., KNOCKS, D., WEISS, C., and WARGNER, T., 1993, Effect of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide. Cancer Research, 53, 4268–4272.
   PubMed Web of Science ®Google Scholar
• WIENTJES, M. G., BADALAMENT, R. A., and Au, J. L.-S., 1993, Use of pharmacological data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer. Cancer Chemotherapy Pharmacology, 32, 255–262.
   PubMed Web of Science ®Google Scholar
• WONG, K-H., and URANO, M., 1992, Enhancement of misonizazole chemosensitization effect by mild hyperthermia. International Journal of Radiation Oncology, Biology and Physics, 23, 593–598.
   PubMed Web of Science ®Google Scholar
• WOODHALL, B., PICKRELL, K. L., GEORGIADE, N. G., MAHALEY, JR., M. S., and DUKES, H. T., 1960, Effect of hyperthermia upon cancer chemotherapy; application to external cancers of head and face structures. Annals of Surgery, 151, 750–759.
   Google Scholar